The company plans to use the raised funds to develop content and to strengthen its business in the United States (US), which accounts for more than half of the user base followed by India, the United Kingdom, and Australia.
The start-up eyes revenues through premium content, monthly subscriptions, and one-on-one consultancy. The company will run a pilot project by the end of this year and roll out premium content by early 2018.
“People are deeply entrenched in allopathy, though the trend is changing in the US, and to get enough doctors to understand and support patients is definitely a challenge,” says Jayaraman.
The start-up aims to build traffic and increase the number of repeat users. With an eight-member team, the company currently focuses on 11 chronic health conditions, including cardiac diseases, mental health and depression, Alzheimer’s, osteoporosis, respiratory illnesses, and insomnia.